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antitumor,[5] anti‑inflammatory,[6] analgesic,[6] and anticancer[7] 
activities. Pain directly related to cancer or caused 
by treatments for cancer is a highly prevalent clinical 
problem. Therefore, analgesics and anti-inflammatory 
drugs are prescribed simultaneously along with cancer 
chemotherapeutics, in normal practice. Due to great 
potential of both the moieties, synthesis of pyrazoline 
bearing thiophene [IVa–d, Va–d] was carried out to evaluate 
antitumor, anti‑inflammatory, and analgesic potential.
Pyrazolines are synthesized from the intermediate 
chalcones by the condensation of 2-acetyl thiophene with 
substituted benzaldehydes. Chalcones are of great interest 
as compounds exhibiting antimalarial,[8] anticancer,[9] 
antioxidant,[9] analgesic,[10] and anti‑inflammatory[10] activities.
INTRODUCTION
Recently, different authors worldwide have reported 
antitumor, antiproliferative, or anticancer potential of 
thiophene,[1] and pyrazoline derivatives.[2] This gave us 
immense confidence to carry out work on pyrazoline which 
possesses antitubercular,[3] antidepressant,[4] anticonvulsant,[4] 
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AbSTRACT
Nitrogen heterocyclic compounds such as pyrazolines have been found to possess a broad spectrum of 
biological activities such as anticancer, antitubercular, anti-inflammatory, analgesic, and antidepressant 
activities. Pyrazoline derivatives IV, V (a–e) have been synthesized from the intermediate chalcones III (a–h) 
by cyclizing with phenyl hydrazine and hydrazine hydrate. The structures of these compounds were confirmed 
by IR, NMR, and mass spectroscopy. Biological studies of the synthesized compounds showed promising 
antitumor, analgesic, and anti-inflammatory activities. The compounds were tested for their in vitro antitumor 
activity against EAC tumor cell lines. Compounds IVa and IVb showed the highest cytotoxicity of 80% at a 
200 µg mL concentration. Among the tested compounds, IVa and Vd seem to be more effective analgesic 
agents. Compounds IVc, IVd, and Ve are found to be the most effective anti-inflammatory agents. Thus the 
results show that synthesized compounds possess antitumor, analgesic, and anti-inflammatory activity. It was 
observed that the test compounds with electron withdrawing groups (halogens) on the aromatic ring favors 
antitumor, analgesic, and anti-inflammatory activity.
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The drug development program has employed testing 
in a few well characterized transplantable animal tumor 
systems. Simple in vitro assays shorten the testing 
program. Here the method is tryphan blue exclusion 
and the tumor cell lines are Ehrlich Ascites Carcinoma 
(EAC).[11]
MATERIALS AND METHODS
Melting points were determined by the capillary method 
and were uncorrected. The IR spectra are recorded by 
using a Shimadzu Perkin Ekmer 8201 PC IR Spectrometer 
and using a thin film on potassium bromide pellets 
techniques and frequencies are expressed in cm−1. The 
PMR spectra were recorded on a Bruker Avance II 
400 NMR spectrometer. All spectra were obtained in 
CDCl3 and Dimethyl sulphoxide (DMSO). Chemical 
shift values are reported as values in ppm relative to TMS 
(δ=0) as an internal standard. The FAB mass spectra were 
recorded on a JEOL SX-102/DA-6000 Mass spectrometer 
using Argon/Xenon (6 kV, 10 Ma) as the FAB gas. All the 
animal experiments were approved by institutional animal 
ethical committee (IAEC).
General procedure for synthesis of chalcones
A mixture of 2‑acetyl thiophene (0.01 mol) and substituted 
benzaldehydes (0.01 mol) in ethanol (20 ml) were stirred 
together for 24 h, in the presence of 20% NaOH (4 ml). 
The mixture was poured into crushed ice and acidified with 
5% HCl. The product (substituted chalcones) obtained 
was filtered, washed with water, and re‑crystallized from 
suitable solvents [Table 1].
3‑(4‑Fluorophenyl)‑1‑(thiophen‑2‑yl) prop‑2‑en‑1‑one
IR (KBr, cm-1): 1648.9 (CO), 1596.4 (aliphatic C=C), 3067.7 
(C–H), 1516 (aromatic C=C), 1216.2 (C–F); 1H NMR 
(δ ppm): 7.79 (d, 1H,=CH), 7.18 (d, 1H,=CH), 7.52–7.87 
(m, 7H, Ar-H); Mass (m/z): 232.
3‑(4‑Chlorophenyl)‑1‑(thiophen‑2‑yl)prop‑2‑en‑1‑one
IR (KBr cm-1): 1672.8 (CO) group, 1611.3 (aliphatic C=C), 
2924.1 (C–H), 1533.7 (aromatic C=C), 765.3 (C–Cl); 
1H NMR (δ ppm): 6.97–6.99 (d, 1H,=CH), 6.71–6.72 
(d, 1H,=CH), 7.53–7.89 (m, 7H, Ar–H); Mass (m/z): 248.
3‑(4‑Methylphenyl)‑1‑(thiophen‑2‑yl) prop‑2‑en‑1‑one
IR (KBr cm-1): 1683.5 (CO), 1609.7 (aliphatic C=C), 2987.3 
(C-H), 1523.5 (aromatic C=C), 765.3 (C–Cl); 1H NMR 
(δ ppm): 7.12–7.14 (d, 1H,=CH), 7.17–7.19 (d, 1H,=CH), 
7.51–7.899 (m, 7H, Ar–H); Mass (m/z): 228.
General procedure for synthesis of pyrazolines
A mixture of substituted chalcones (0.01 mol) in 20 ml 
of ethanol and phenyl hydrazine, hydrazine hydrate 
(0.01 mol) were added and refluxed for 5–8 h and 
16–20 h, respectively, in the presence of few drops of 
pyridine as catalyst. After the completion of the reaction, 
the reaction mixture was poured into 250 ml of ice cold 
water. The solid separated is filtered and washed with cold 
water. The separated compound is recrystallized by using 
methanol/ethyl acetate. Ethyl acetate: acetone (9:1) is the 
solvent system for TLC [Table 2].
5‑(4‑Fluorophenyl)‑1‑phenyl‑3‑(thiophen‑2‑yl)‑4,5‑dihydro‑1H‑
pyrazole
IR (KBr cm-1): 3431 (C–H), 1646.8 (C=N), 1324.3 
(C–N), 1594.7 (C=C), 1224.9 (C–F); 1H NMR (δ ppm): 
3.064–3.124 (dd, 1H, Ha), 3.786–3.859 (dd, 1H, Hb), 
5.213–5.261 (dd, 1H, Hc), 6.76–7.31 (m, 12H, Ar–H); 
Mass (m/z): 322.
5‑(4‑Chlorophenyl)‑1‑phenyl‑3‑(thiophen‑2‑yl)‑4, 5‑dihydro‑1H‑
pyrazole
IR (KBr cm-1): 3039.6 (C–H), 1635.6 (C=N), 1336.7 (C–N), 
1522.5 (C=C), 703.8 (C–Cl); 1H NMR (δ ppm): 3.049–3.109 
(dd, 1H, Ha), 3.779–3.852 (dd, 1H, Hb), 5.190–5.239 (dd, 
1H, Hc), 6.769–7.308 (m, 12H, Ar–H); Mass (m/z): (M+) 
338, (M++2) 340.
5‑(4‑Fluorophenyl)‑3‑(thiophen‑2‑yl)‑4,5‑dihydro‑1H‑pyrazole
IR (KBr cm-1): 3239.2 (C–H), 1546.3 (C=N), 1499.33 
Table 1: Physical data of substituted chalcone 
derivatives
Chalcones R Molecular formula MP (°C) % Yield
IV 4-Cl C13H9ClOS 80–82 78
IVb 4-F C13H9FOS 83–85 75
IVc 4-OH C13H10O2S 104–106 62
IVd 4-N(CH3)2 C15H15NOS 87–89 68
Va 4-CH3 C14H12OS 96–98 77
Vb 3-OH C13H10O2S 88–90 68
Vc 3-Cl C13H9ClOS 92–95 63
Vd 3-NO2 C13H9NO3S 111–112 68
Table 2: Physical data of the synthesized pyrazolines
Pyrazolines R Molecular formula MP (°C) % Yield
IV 4-Cl C19H15ClN2S 153–155 69
IVb 4-F C19H15FN2S 158–160 71
IVc 4-CH3 C20H18N2S 106–108 55
IVd 3-NO2 C19H15N3O2S 175–177 49
Va p-Cl C13H11ClN2S 171–174 68
Vb p-F C13H11FN2S 159–161 65
Vc p-CH3 C14H14N2S 88–90 43
Vd m-NO2 C13H11N3O2S 145–147 5184   Journal of Young Pharmacists Vol 4 / No 2
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(C–N), 1523.9 (C=C), 1197.3 (C–F); 1H NMR (δ ppm): 
3.064–3.124 (dd, 1H, Ha), 3.786–3.859 (dd, 1H, Hb), 
5.213–5.261 (dd, 1H, Hc), 6.76–7.31 (m, 12H, Ar–H); 
Mass (m/z): 246.
5‑(4‑Chlorophenyl)‑3‑(thiophen‑2‑yl)‑4,5‑dihydro‑1H‑pyrazole
IR (KBr cm-1): 3141.1 (C–H), 1689.6 (C=N), 1421.3 (C–N), 
1583.9 (C=C), 737.2 (C–Cl); 1H NMR (δ ppm): 3.106–3.198 
(dd, 1H, Ha), 3.657–3.748 (dd, 1H, Hb), 5.891–5.931 (dd, 
1H, Hc), 6.331–7.05 (m, 12H, Ar–H); Mass (m/z): (M+) 
262, (M++2) 264.
Antitumor activity
The synthesized compounds were tested for their 
cytotoxicity in vitro, in comparison with 5‑fluorouracil as 
a reference drug, against EAC cells. EAC cells (1 × 106) 
were incubated with synthesized compounds at various 
concentrations of 25, 50, 100, and 200 µg/ml, in 1 ml 
phosphate buffered saline (incorporated with 10 µL 
DMSO) at 37°C for 3 h. Viable cells were counted in 
a hemocytometer using the tryphan blue dye exclusion 
method.[12] Experiments were carried out in triplicate, and 
results are reported in Table 3.
Pharmacological screening
Animals
Adult female albino rats were used for acute toxicity studies. 
The acute toxicity test was carried out according to the 
organization for economic co-operation and development 
(OECD) guidelines to establish the effective dose of 
the test compounds after obtaining ethical clearance 
from ethics committee of K.S. Hegde Medical Academy, 
Deralakatte, Mangalore, India (Ethical Clearance Reg. No. 
KSHEMA/AEC/093/2009).
Acute toxicity
Adult female albino rats weighing 150–230 g were 
grouped into six groups of six animals each, starved 
for 24 h. On the day of the experiment, animals were 
orally administered different compounds to different 
groups with an increasing dose of 10, 20, 100, 200, 1000, 
and 2000 mg/kg body weight. Then, the animals were 
observed continuously for 3 h concerning the general 
behavioral, neurological, and autonomic profiles, then, 
every 30 min for the next 3 h, and finally for the next 
24 h or until death.
Analgesic activity
The analgesic activity of the test compounds was carried 
out in vivo by the tail immersion method.[13] Pentazocine 
(10 mg/kg) was administered as standard for comparison 
and test compounds at a dose level of 50 mg/kg were 
administered orally. The lower portion of the tail was 
immersed in the thermostatic organ bath in which water 
is maintained at exactly 55°C. Within few seconds the 
rat reacts by withdrawing the tail. The reaction times 0, 
30, 60, 90, and 120 min after the treatment of the test 
substance were noted. Increased or decreased in reaction 
time of the test substance was then compared with 
standard drug treated and solvent treated. The results 
are given in Table 4.
Percentage increase in reaction time=[(Rt/Rc)-1)×100,
where Rt is mean reaction time of the treated group and 
Rc is mean reaction time of control group.
Anti‑inflammatory activity
The anti-inflammatory of the test compounds was 
carried out using the carrageenan-induced rat paw edema 
inhibition method according to Winter et al.[14] Acute 
inflammation was produced by subplantar injection of 
0.1 ml of 1% suspension of carrageenan in the right hind 
paw of the rats, 30 min after oral administration of the 
drugs. The paw volume was measured plethysmometrically 
(IITC digital plethysmograph IITC-520) at 1, 2, 3, and 
Table 3: Antitumor activities of synthesized pyrazolines
Pyrazolines No. of dead cells (%) at different 
concentrations (µg/ml)
50 100 200 250
Control 
IV 20 45 68 78
IVb 26 28 58 65
IVd 16 20 27 43
Va 10 15 42 55
Vb 14 17 22 32
5-Fluorouracil 45 80  100 100
Table 4: Analgesic activities of synthesized pyrazolines
Treatment Reaction time in sec at time (min)
30 60 90 120
Control 2.27 ± 0.03 2.65 ± 0.02 2.83 ± 0.03 2.75 ± 0.04
Pentazocine 5.21 ± 0.04** 7.34 ± 0.02** 8.7 ± 0.10** 5.38 ± 0.09**
IV 4.8 ± 0.04** 6.9 ± 0.02** 8.33 ± 0.05** 5.9 ± 0.03*
IVb 4.3 ± 0.04** 6.2 ± 0.05** 7.9 ± 0.03** 5.3 ± 0.05**
IVc 2.38 ± 0.02 2.99 ± 0.03* 3.99 ± 0.04* 3.87 ± 0.02*
IVd 2.22 ± 0.03 2.9 ± 0.04* 3.10 ± 0.04* 2.92 ± 0.04*
IVe 4.5 ± 0.02** 6.8 ± 0.04** 8.0 ± 0.03** 6.8 ± 0.04**
Va 4.6 ± 0.04** 6.4 ± 0.03** 7.9 ± 0.03** 5.67 ± 0.03**
Vb  3.75 ± 0.03** 6.03 ± 0.03** 7.77 ± 0.04** 4.9 ± 0.03**
Vc 2.39 ± 0.02 3.24 ± 0.03* 3.95 ± 0.03* 3.5 ± 0.03*
Vd 4.76 ± 0.03** 6.13 ± 0.03** 8.12 ± 0.02** 5.15 ± 0.03**
Ve 4.29 ± 0.03** 6.45 ± 0.03** 8.2 ± 0.03 5.58 ± 0.04*
Values are expressed as mean±SEM of six animals in each group. *Statistically 
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Table 5: Anti-inflammatory activities of synthesized 
pyrazolines
Treatment Mean paw volume at different time intervals
1 h 2 h 3 h 4 h
Control 0.46 ± 0.01 0.68 ± 0.01 0.79 ± 0.01 0.88 ± 0.01
Indomethacin 0.22 ± 0.01** 0.20 ± 0.01** 0.19 ± 0.01** 0.11 ± 0.01**
IV 0.39 ± 0.02** 0.35 ± 0.02** 0.34 ± 0.02** 0.21 ± 0.01**
IVb 0.45 ± 0.02* 0.38 ± 0.01* 0.31 ± 0.03* 0.29 ± 0.02*
IVc 0.23 ± 0.01** 0.21 ± 0.01** 0.20 ± 0.02** 0.18 ± 0.02**
IVd 0.28 ± 0.01* 0.25 ± 0.02* 0.21 ± 0.02* 0.15 ± 0.01*
IVe 0.41 ± 0.01* 0.37 ± 0.02* 0.32 ± 0.03* 0.27 ± 0.02*
Va 0.35 ± 0.02** 0.30 ± 0.02** 0.28 ± 0.01** 0.19 ± 0.01**
Vb 0.42 ± 0.01* 0.39 ± 0.03* 0.30 ± 0.01* 0.25 ± 0.01*
Vc 0.38 ± 0.01** 0.35 ± 0.02** 0.27 ± 0.02** 0.20 ± 0.02**
Vd 0.47 ± 0.01* 0.43 ± 0.02* 0.38 ± 0.01* 0.31 ± 0.01*
Ve 0.29 ± 0.02** 0.26 ± 0.01** 0.23 ± 0.02** 0.17 ± 0.01**
Values are expressed as mean±SEM of six animals in each group. *Statistically 
significant (P≤0.05). **Statistically significant (P≤0.001)
4 h after the carrageenan injection. Indomethacin was 
used as the standard drug at a dose level of 10 mg/kg. 
The percentage inhibition of edema was calculated using 
the formula,
% Inhibition=(1−Vt/Vc)×100,
where Vt and Vc is the edema volume in treated and 
control groups, respectively. The results are summarized 
in Table 5.
RESULTS AND DISCUSSION
The sequence of the reactions employed for the development 
of novel pyrazoline derivatives is outlined in Scheme 1. 
Chalcones III (a–h) were synthesized by the condensation of 
2-acetyl thiophene I with various substituted benzaldehydes 
II in the presence of NaOH. This chalcones on cyclization 
with phenyl hydrazine and hydrazine hydrate gave 
pyrazolines IV, V (a–e), respectively, in the presence of 
pyridine as catalyst.
The structures of newly synthesized compounds are well 
supported by spectral data such as IR, NMR, and Mass 
spectral analysis. The formation of title compounds IV, V 
(a–e) is indicated by the disappearance of peak due to C=O 
of the intermediate chalcones and the presence of peaks 
due to C=N of the pyrazoline ring in IR spectra as given 
above. Further, in their 1H NMR spectrum, the appearance 
of a signal at δ 3.064–3.124 (dd, 1H, Ha), 3.786–3.859 (dd, 
1H, Hb), 5.213–5.261 (dd, 1H, Hc), confirms the presence 
of the pyrazoline ring.
All the tested compounds showed antitumor effects and 
are reported. Compounds IVa and IVb showed the highest 
Structures of synthesized compounds IR spectra
2
6
)
IOXRURSKHQ\OWKLRSKHQ\OSURSHQRQH
1648.9 (CO),
1596.4 (aliphatic C = C),
3067.7 (C–H),
1516 (aromatic C = C), 
1216.2 (C–F)
2
6
&O
FKORURSKHQ\OWKLRSKHQ\OSURSHQRQH
1672.8 (CO) group, 
1611.3 (aliphatic C = C),
2924.1 (C–H),
1533.7 (aromatic C = C),
765.3 (C–Cl)
2
6
PHWK\OSKHQ\OWKLRSKHQ\OSURSHQRQH
1683.5 (CO),
1609.7 (aliphatic C = C),
2987.3 (C–H),
1523.5 (aromatic C = C)
1
1
6
)
IOXRURSKHQ\OSKHQ\OWKLRSKHQ\OGLK\GUR+S\UD]ROH
3431 (C–H),
1646.8 (C = N),
1324.3 (C–N),
1594.7 (C = C),
1224.9 (C–F)
1
1
6
&O
FKORURSKHQ\OSKHQ\OWKLRSKHQ\OGLK\GUR+S\UD]ROH
3039.6 (C–H),
1635.6 (C = N),
1336.7 (C–N),
1522.5 (C = C),
703.8 (C–Cl).
+1
1
6
&O
FKORURSKHQ\OWKLRSKHQ\OGLK\GUR+S\UD]ROH
3239.2 (C–H),
1546.3 (C = N),
1499.33 (C–N),
1523.9 (C = C),
1197.3 (C–F).
+1
1
6
)
IOXRURSKHQ\OWKLRSKHQ\OGLK\GUR+S\UD]ROH
3141.1 (C–H),
1689.6 (C = N),
1421.3 (C–N),
1583.9 (C = C),
737.2 (C–Cl)
cytotoxicity of 80% at a 200 µg mL concentration. The 
cytotoxicity activity was expressed as percentage of dead 
cells. Among the tested compounds, IVa and Vd seem to 
be more effective analgesic agents. The analgesic activity 
was expressed as percentage increase in reaction time. 86   Journal of Young Pharmacists Vol 4 / No 2
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Compounds IVc, IVd, and Ve are found to be the most 
effective anti‑inflammatory agents. The results indicate 
the percentage inhibition of inflammatory.
CONCLUSION
Thus the results show that synthesized compounds 
possess antitumor, analgesic, and anti-inflammatory 
activities. Their synthesis was simple with satisfactory 
yields. It was observed that the test compounds with 
electron withdrawing groups (halogens) on the aromatic 
ring favors antitumor, analgesic, and anti‑inflammatory 
activities. However, further studies are required to 
establish the exact mechanism of action.
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